Blog
RSS FeedPosted by Michael Wonder on 22 May 2019
HHS marches forward to enhance drug price transparency
21 May 2019 - HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to ...
Posted by Michael Wonder on 22 May 2019
House Committee proposes 6% increase in FDA funding for FY 2020
22 May 2019 - The House Appropriations Committee on Wednesday released a draft fiscal year 2020 funding bill for the ...
Posted by Michael Wonder on 22 May 2019
Free market activists slam Trump's international drug pricing index
21 May 2019 - Rep. Andy Biggs: 'Seems to me like we're importing drug controls'. ...
Posted by Michael Wonder on 21 May 2019
Louisiana is creating a drug price revolution
20 May 2019 - Louisiana is putting the final touches on a revolutionary deal that promises to simultaneously control health ...
Posted by Michael Wonder on 21 May 2019
FDA replaces withdrawn biosimilar guidance with new one on quality-related considerations
21 May 2019 - A week after finalizing guidance on developing interchangeable biosimilars, the US FDA has drafted guidance for ...
Posted by Michael Wonder on 21 May 2019
Framework for the regulation of regenerative medicine products
21 May 2019 - The U.S. FDA has published four final guidance documents that are part of a comprehensive policy framework ...
Posted by Michael Wonder on 21 May 2019
South Africa's Aspen sells Australian prescription portfolio to Mylan
20 May 2019 - Aspen Pharmacare has said that Mylan had exercised an option to buy the South African drug ...
Posted by Michael Wonder on 21 May 2019
New made-in-Canada technique could revolutionise vaccine transportation
21 May 2019 - Researchers in Ontario have developed a new method of transporting life-saving vaccines to remote and impoverished ...
Posted by Michael Wonder on 20 May 2019
Trump administration postpones some Medicare drug cost proposals
17 May 2019 - The administration says it will not give health plans the authority to negotiate pricing for certain drugs ...
Posted by Michael Wonder on 20 May 2019
Korean Government to reduce biopharmaceutical approval period to half
20 May 2019 - The Korean government plans to reduce by half the current one and a half years of ...
Posted by Michael Wonder on 20 May 2019
FDA's strengthened global inspection program helps ensure generic drug safety
17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines. ...
Posted by Michael Wonder on 19 May 2019
Trump Administration caves to pharma on Medicare Part D 'protected classes' reform
17 May 2019 - The Trump administration has shelved a proposal that would have stymied egregious price hikes in the ...
Posted by Michael Wonder on 19 May 2019
San Francisco, Santa Clara, Alameda counties join Governor Newsom to lower drug prices
16 May 2019 - San Francisco, Santa Clara and Alameda counties joined on Thursday Governor Gavin Newsom’s ambitious plan to ...
Posted by Michael Wonder on 19 May 2019
Trump administration backs off Medicare drug pricing rule
16 May 2019 - The Trump administration on Thursday backed off a controversial Medicare drug pricing proposal that would have ...
Posted by Michael Wonder on 19 May 2019
House passes legislation aiming to shore up health law and lower drug costs
16 May 2019 - The House on Thursday passed a suite of health care bills that tied shoring up the ...